In myeloid cells, aberrant STAT3 activation contributes to lung cancer progression by recruiting immunosuppressive cell including regulatory T cells (Tregs), MDSCs and alternatively activated macrophages (M2 macrophage) into the TME. Here, STAT3 is linked to lung carcinoma.